Van beleggers
voor beleggers
desktop iconMarkt Monitor

Inloggen

  • Geen account? Registreren

Wachtwoord vergeten?

Minerva Neurosciences: NERV

14 Posts
| Omlaag ↓
  1. forum rang 7 Profitmaker 23 maart 2017 13:28
    Zacks: Analysts Set $17.00 Target Price for Minerva Neurosciences Inc (NERV)

    March 23rd, 2017 - By Amy Steele - 0 comments








    Minerva Neurosciences logoShares of Minerva Neurosciences Inc (NASDAQ:NERV) have received a consensus broker rating score of 0.00 () from the one brokers that cover the company, Zacks Investment Research reports. One research analyst has rated the stock with a strong buy recommendation.

    Brokers have set a one year consensus price objective of $17.00 for the company and are expecting that the company will post ($0.30) EPS for the current quarter, according to Zacks. Zacks has also given Minerva Neurosciences an industry rank of 108 out of 265 based on the ratings given to its competitors.

    A number of analysts have recently issued reports on NERV shares. Zacks Investment Research upgraded Minerva Neurosciences from a “sell” rating to a “hold” rating in a report on Friday, March 17th. Jefferies Group LLC started coverage on Minerva Neurosciences in a report on Monday, March 6th. They set a “buy” rating and a $17.00 target price for the company.
14 Posts
|Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met je emailadres en wachtwoord

Direct naar Forum

Indices

AEX 773,16 +0,08%
EUR/USD 1,1343 +0,01%
FTSE 100 7.580,51 -0,12%
Germany40^ 15.786,90 -0,14%
Gold spot 1.837,57 -0,15%
NY-Nasdaq Composite 14.340,26 -1,15%

Stijgers

PROSUS
+4,03%
UMG
+3,24%
Alfen ...
+2,91%
Galapagos
+2,04%
Basic-Fit
+1,34%

Dalers

ASMI
-4,48%
Philip...
-2,67%
UNIBAI...
-2,60%
BESI
-2,55%
Euroco...
-2,30%

Lees verder op het IEX netwerk Let op: Artikelen linken naar andere sites

Gesponsorde links